These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 168277)

  • 1. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
    Hazzard ER; Bierman EL
    J Lab Clin Med; 1975 Aug; 86(2):239-52. PubMed ID: 168277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed clearance of chylomicron remnants following vitamin-A-containing oral fat loads in broad-beta disease (type III hyperlipoproteinemia).
    Hazzard WR; Bierman EL
    Metabolism; 1976 Jul; 25(7):777-801. PubMed ID: 181657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catabolism of very-low-density lipoproteins in subjects with broad beta disease: comparison with endogenous hypertriglyceridemia.
    Kushwaha RS; Chait A; Hazzard WR
    J Lab Clin Med; 1982 Jan; 99(1):15-24. PubMed ID: 6948063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Broad-beta disease versus endogenous hypertriglyceridemia: levels and lipid composition of chylomicrons and very low density lipoproteins during fat-free feeding and alimentary lipemia.
    Hazzard WR; Bierman EL
    Metabolism; 1975 Jul; 24(7):817-28. PubMed ID: 166269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired very low density lipoprotein and triglyceride removal in broad beta disease: comparison with endogenous hypertriglyceridemia.
    Chait A; Hazzard WR; Albers JJ; Kushwaha RP; Brunzell JD
    Metabolism; 1978 Sep; 27(9):1055-66. PubMed ID: 210351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P; Schwandt P
    Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On thelipoprotein abnormality in type 3 hyperlipoproteinemia.
    Quarfordt S; Levy RI; Fredrickson DS
    J Clin Invest; 1971 Apr; 50(4):754-61. PubMed ID: 5547274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of behaviour of very low density lipoproteins of type III hyperlipoproteinaemia on electrophoresis on paper and on agarose gel with a note on a late (slow) pre-beta VLDL liproprotein.
    Carlson K; Carlson LA
    Scand J Clin Lab Invest; 1975 Nov; 35(7):655-60. PubMed ID: 174185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conversion of the electrophoretic pattern of type IV hyperlipidaemia to type III by intravenous heparin.
    Olsson AG; Carlson LA; Carlson K
    Acta Med Scand; 1978; 203(6):487-90. PubMed ID: 208351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Type III hyperlipoproteinemia: paradoxical hypolipidemic response to estrogen.
    Kushwaha RS; Hazzard WR; Gagne C; Chait A; Albers JJ
    Ann Intern Med; 1977 Nov; 87(5):517-25. PubMed ID: 200161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compositional and metabolic heterogeneity of alpha 2- and beta-very-low-density lipoproteins in subjects with broad beta disease and endogenous hypertriglyceridemia.
    Kushwaha RS; Haffner SM; Foster DM; Hazzard WR
    Metabolism; 1985 Nov; 34(11):1029-38. PubMed ID: 4058307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the classical methods for the diagnosis of type III hyperlipoproteinemia.
    Patsch JR; Jackson RL; Gotto AM
    Klin Wochenschr; 1977 Nov; 55(21):1025-30. PubMed ID: 200792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR; Yeshurun D; Jackson RL; Gotto AM
    Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW; Sacks FM
    J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diurnal patterns of plasma lipids and lipoproteins in primary endogenous hypertriglyceridemia (type IV-hyperlipoproteinemia) (author's transl)].
    Schlierf G; Oster P; Seidel D; Raetzer H; Schellenberg B; Heuck CC; Wicklein RL
    Klin Wochenschr; 1977 Feb; 55(4):161-7. PubMed ID: 190438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum lipoprotein composition in different types of hyperlipoproteinemia.
    Carlson LA
    Adv Exp Med Biol; 1975; 63():185-99. PubMed ID: 173148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Properties of the plasma very low and low density lipoproteins in Tangier disease.
    Heinen RJ; Herbert PN; Fredrickson DS
    J Clin Invest; 1978 Jan; 61(1):120-32. PubMed ID: 201668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The composition of low (LDL) and very low (VLDL) density lipoprotein subfractions in type III hyperlipoproteinaemia: comparison with normal subjects.
    Stromber P; Ballantyne D; Ballantyne FC; Third JL; Bedford DK
    Clin Chim Acta; 1977 Aug; 79(1):163-72. PubMed ID: 196790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet.
    Vessby B; Carlson LA
    Eur J Clin Invest; 1975 Jul; 5(4):359-64. PubMed ID: 170119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.